Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver diamine fluoride for arresting dental caries in children in Lagos, Nigeria
PACTR201908699150281Phase 3Not yet recruiting
- Sponsor
- Dr OKECHUKWU MOSES AZUORU
- Start
- Jan 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of silver diamine fluoride in carious lesion (2 arms), sponsored by Dr OKECHUKWU MOSES AZUORU. Primary endpoint: Arrested caries. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
silver diamine fluoride
03
Conditions
carious lesion
Beyond the preview
Go deeper on PACTR201908699150281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201908699150281.